The role and relevance of mast cells in urticaria

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Immunological Reviews

• Publication date

  2018-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/imr.12632PMID 29431202
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mast cells are critical for the limitation of thrombin‐induced skin inflammation

  2018cited by this paper
• In chronic spontaneous urticaria, high numbers of dermal endothelial cells, but not mast cells, are linked to recurrent angio‐oedema

  2018cited by this paper
• Benefit from reslizumab treatment in a patient with chronic spontaneous urticaria and cold urticaria

  2018cited by this paper
• Different expression patterns of plasma Th1‐, Th2‐, Th17‐ and Th22‐related cytokines correlate with serum autoreactivity and allergen sensitivity in chronic spontaneous urticaria

  2018cited by this paper
• Autoimmune chronic spontaneous urticaria: What we know and what we do not know

  2017cited by this paper
• Serum autoreactivity predicts time to response to omalizumab therapy in chronic spontaneous urticaria.

  2017cited by this paper
• Comorbidity of chronic spontaneous urticaria and autoimmune thyroid diseases: A systematic review

  2017cited by this paper
• Neuroendocrinology of mast cells: Challenges and controversies

  2017cited by this paper
• Omalizumab treatment in patients with chronic inducible urticaria: A systematic review of published evidence

  2017cited by this paper
• Action protectrice des éthers phénoliques au cours de l’intoxication histaminique

  2017cited by this paper
• NGF and Its Receptors in the Regulation of Inflammatory Response

  2017cited by this paper
• SP and IL-33 together markedly enhance TNF synthesis and secretion from human mast cells mediated by the interaction of their receptors

  2017cited by this paper
• Analysis of the changes in Th9 cells and related cytokines in the peripheral blood of spontaneous urticaria patients

  2017cited by this paper
• Interleukin (IL) 31 induces in cynomolgus monkeys a rapid and intense itch response that can be inhibited by an IL‐31 neutralizing antibody

  2017cited by this paper
• IL‐24 is a common and specific autoantigen of IgE in patients with chronic spontaneous urticaria

  2017cited by this paper
• Frontline Science: Corticotropin‐releasing factor receptor subtype 1 is a critical modulator of mast cell degranulation and stress‐induced pathophysiology

  2017cited by this paper
• Detection of circulating IgG autoantibody to FcεRIα in sera from chronic spontaneous urticaria patients.

  2017cited by this paper
• The relationship between circulating concentrations of interleukin 17 and C reactive protein in chronic spontaneous urticaria

  2017cited by this paper
• Brain-derived neurotrophic factor is increased in serum levels of patients with symptomatic dermographism

  2017cited by this paper
• Upregulated expression of substance P (SP) and NK1R in eczema and SP-induced mast cell accumulation

  2017cited by this paper
• The Role of Neurotrophins in Inflammation and Allergy.

  2017cited by this paper
• Basophil CD63 expression in chronic spontaneous urticaria: correlation with allergic sensitization, serum autoreactivity and basophil reactivity

  2017cited by this paper
• Association of TG2 from mast cells and chronic spontaneous urticaria pathogenesis.

  2016cited by this paper
• Autoreactive T cells in chronic spontaneous urticaria target the IgE Fc receptor Iα subunit.

  2016cited by this paper
• Increase of Mast Cell-Nerve Association and Neuropeptide Receptor Expression on Mast Cells in Perennial Allergic Rhinitis

  2016cited by this paper
• Upregulated expression of substance P in basophils of the patients with chronic spontaneous urticaria: induction of histamine release and basophil accumulation by substance P

  2016cited by this paper
• IL-33 and Thymic Stromal Lymphopoietin in mast cell functions.

  2016cited by this paper
• Periostin and Interleukin-13 Are Independently Related to Chronic Spontaneous Urticaria

  2016cited by this paper
• Aktuelles zur kutanen Neurobiologie von Pruritus

  2016cited by this paper
• Altered Systemic Adipokines in Patients with Chronic Urticaria

  2016cited by this paper
• Biomarkers of the involvement of mast cells, basophils and eosinophils in asthma and allergic diseases

  2016cited by this paper
• [Update on the cutaneous neurobiology of pruritus].

  2016cited by this paper
• Association among stress, hypocortisolism, systemic inflammation, and disease severity in chronic urticaria.

  2016cited by this paper
• Elevated Plasma Level of Interferon-λ1 in Chronic Spontaneous Urticaria: Upregulated Expression in CD8+ and Epithelial Cells and Induction of Inflammatory Cell Accumulation

  2016cited by this paper
• IL-33/ST2 signaling excites sensory neurons and mediates itch response in a mouse model of poison ivy contact allergy

  2016cited by this paper
• Identification of a Th2‐ and Th17‐skewed immune phenotype in chronic urticaria with Th22 reduction dependent on autoimmunity and thyroid disease markers

  2016cited by this paper
• Successful omalizumab treatment in chronic spontaneous urticaria is associated with lowering of serum IL‐31 levels

  2016cited by this paper
• Systemic inflammatory response and calcification markers in patients with long lasting moderate-severe chronic spontaneous urticaria

  2015cited by this paper
• The potential pharmacologic mechanisms of omalizumab in patients with chronic spontaneous urticaria.

  2015cited by this paper
• The role of IL-33 and mast cells in allergy and inflammation

  2015cited by this paper
• The role of the IL-33/IL-1RL1 axis in mast cell and basophil activation in allergic disorders.

  2015cited by this paper
• An Interleukin-33-Mast Cell-Interleukin-2 Axis Suppresses Papain-Induced Allergic Inflammation by Promoting Regulatory T Cell Numbers.

  2015cited by this paper
• Mast cell production and response to IL-4 and IL-13.

  2015cited by this paper
• Activation of Blood Coagulation in Two Prototypic Autoimmune Skin Diseases: A Possible Link with Thrombotic Risk

  2015cited by this paper
• Elevations in T‐helper‐2‐initiating cytokines (interleukin‐33, interleukin‐25 and thymic stromal lymphopoietin) in lesional skin from chronic spontaneous (‘idiopathic’) urticaria

  2015cited by this paper
• IL-6 Transsignaling in Patients with Chronic Spontaneous Urticaria

  2015cited by this paper
• Increased thrombin generation potential in patients with chronic spontaneous urticaria.

  2015cited by this paper
• Management and treatment of chronic urticaria (CU)

  2015cited by this paper
• Chronic urticaria and coagulation: pathophysiological and clinical aspects

  2014cited by this paper
• Correlations between Anti-Mast Cell Autoantibodies and Chronic Idiopathic Urticaria

  2014cited by this paper
• Neuropeptide NGF mediates neuro-immune response and inflammation through mast cell activation.

  2014cited by this paper
• Functional characterization of histamine H4 receptor on human mast cells.

  2014cited by this paper
• Circulating level of CD4+ CD25+ FOXP3+ T cells in patients with chronic urticaria

  2014cited by this paper
• Elevations in vascular markers and eosinophils in chronic spontaneous urticarial weals with low-level persistence in uninvolved skin

  2014cited by this paper
• The EAACI/GA(2) LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update.

  2014cited by this paper
• Interleukin-33 promotes the proliferation of mouse mast cells through ST2/MyD88 and p38 MAPK-dependent and Kit-independent pathways.

  2014cited by this paper
• Elevated serum IgE against MGL_1304 in patients with atopic dermatitis and cholinergic urticaria.

  2014cited by this paper
• Role of IFN-γ and IL-6 Cytokines and Their Association in Determining Susceptibility to Chronic Idiopathic Urticaria

  2014cited by this paper
• Evaluation of serum neuropeptide levels in patients with chronic urticaria.

  2014cited by this paper
• Nerve Growth Factor Interactions with Mast Cells

  2014cited by this paper
• Serum concentration of IL‐17, IL‐23 and TNF‐α among patients with chronic spontaneous urticaria: association with disease activity and autologous serum skin test

  2014cited by this paper
• Substance P is upregulated in the serum of patients with chronic spontaneous urticaria.

  2014cited by this paper
• Study of serum interleukin (IL) 18 and IL-6 levels in relation with the clinical disease severity in chronic idiopathic urticaria patients of Kashmir (North India)

  2014cited by this paper
• IL-25 Promotes Th2 Immunity Responses in Airway Inflammation of Asthmatic Mice via Activation of Dendritic Cells

  2014cited by this paper
• Omalizumab is an effective and rapidly acting therapy in difficult-to-treat chronic urticaria: a retrospective clinical analysis.

  2014cited by this paper
• 25-Hydroxy vitamin D levels in chronic urticaria and its correlation with disease severity from a tertiary care centre in South India

  2014cited by this paper
• Interleukin‐31 does not induce immediate itch in atopic dermatitis patients and healthy controls after skin challenge

  2014cited by this paper
• A sensory neuron-expressed IL-31 receptor mediates T helper cell-dependent itch: Involvement of TRPV1 and TRPA1.

  2014cited by this paper
• Expression of Mas-related gene X2 on mast cells is upregulated in the skin of patients with severe chronic urticaria.

  2014cited by this paper
• Histamine receptor H4 regulates mast cell degranulation and IgE induced FcεRI upregulation in murine bone marrow-derived mast cells.

  2013cited by this paper
• Histamine, TNF, C5a, IL-6, -9, -18, -31, -33, TSLP, neopterin, and VEGF are not elevated in chronic spontaneous urticaria.

  2013cited by this paper
• Significantly High Levels of Anti-dsDNA Immunoglobulin E in Sera and the Ability of dsDNA to Induce the Degranulation of Basophils from Chronic Urticaria Patients

  2013cited by this paper
• Determination of dermatology life quality index, and serum C-reactive protein and plasma interleukin-6 levels in patients with chronic urticaria

  2013cited by this paper
• Airway epithelial cells initiate the allergen response through transglutaminase 2 by inducing IL-33 expression and a subsequent Th2 response

  2013cited by this paper
• Autoantibodies in chronic idiopathic urticaria and nonurticarial systemic autoimmune disorders.

  2013cited by this paper
• Free IL-18 and IL-33 cytokines in chronic spontaneous urticaria.

  2013cited by this paper
• CCL5/RANTES, sVCAM-1, and sICAM-1 in Chronic Spontaneous Urticaria

  2013cited by this paper
• Up-dosing with bilastine results in improved effectiveness in cold contact urticaria

  2013cited by this paper
• Human IL-31 is induced by IL-4 and promotes TH2-driven inflammation.

  2013cited by this paper
• Platelet oxidative stress and systemic inflammation in chronic spontaneous urticaria

  2013cited by this paper
• The mast cell-nerve functional unit: a key component of physiologic and pathophysiologic responses.

  2012cited by this paper
• Serum IL-9 levels in patients with spontaneous urticaria: a preliminary study.

  2012cited by this paper
• Cold Urticaria Patients Exhibit Normal Skin Levels of Functional Mast Cells and Histamine after Tolerance Induction

  2012cited by this paper
• Interleukin-33 amplifies IgE synthesis and triggers mast cell degranulation via interleukin-4 in naïve mice1

  2012cited by this paper
• Characterization of the inflammatory infiltrate and cytokine expression in the skin of horses with recurrent urticaria.

  2012cited by this paper
• Mast cells orchestrate type 2 immunity to helminths through regulation of tissue-derived cytokines

  2012cited by this paper
• Regulation of type 2 immunity to helminths by mast cells

  2012cited by this paper
• IgE Mediated Autoallergy against Thyroid Peroxidase – A Novel Pathomechanism of Chronic Spontaneous Urticaria?

  2011cited by this paper
• G protein coupled receptor specificity for C3a and compound 48/80-induced degranulation in human mast cells: roles of Mas-related genes MrgX1 and MrgX2.

  2011cited by this paper
• Brain‐derived neurotrophic factor is increased in serum and skin levels of patients with chronic spontaneous urticaria

  2011cited by this paper
• Autologous serum skin test response in chronic spontaneous urticaria and respiratory diseases and its relationship with serum interleukin-18 level

  2011cited by this paper
• Nerve growth factor partially recovers inflamed skin from stress-induced worsening in allergic inflammation.

  2011cited by this paper
• Unmet clinical needs in chronic spontaneous urticaria. A GA2LEN task force report 1

  2011cited by this paper
• Plasma IL‐6 concentration correlates with clinical disease activity and serum C‐reactive protein concentration in chronic urticaria patients

  2011cited by this paper
• Increase of coagulation potential in chronic spontaneous urticaria

  2011cited by this paper
• Serum total tryptase levels are increased in patients with active chronic urticaria

  2010cited by this paper
• IL-33 Is Produced by Mast Cells and Regulates IgE-Dependent Inflammation

  2010cited by this paper
• The role of neurotrophins in inflammation and allergy.

  2010cited by this paper
• Antimicrobial Peptides Human β-Defensins and Cathelicidin LL-37 Induce the Secretion of a Pruritogenic Cytokine IL-31 by Human Mast Cells

  2010cited by this paper
• Stress and the skin.

  2010cited by this paper

• Treatments and Targets to Achieve Disease Control in Chronic Spontaneous Urticaria: Current and Emerging Therapeutic Options

  2026cites this paper
• From neuroimmune circuits to targeted therapy of chronic pruritus

  2026cites this paper
• Chronic Urticaria and Malignancy: A Review Uncovering the Common Links

  2026cites this paper
• Dupilumab in Patients With Chronic Spontaneous Urticaria: Phase 3 LIBERTY-CSU CUPID Randomized Clinical Trials.

  2026cites this paper
• Dupilumab, a new addition to the armamentarium for the management of chronic spontaneous urticaria: A narrative review

  2026cites this paper
• A Case Series of Tofacitinib Treatment for Chronic Spontaneous Urticaria with Inadequate Response to Omalizumab

  2026cites this paper
• Impact of Vitamin D Deficiency on Clinical Severity and Recurrence Rate in Patients with Chronic Urticaria

  2026cites this paper
• WGCNA-guided network pharmacology identifies therapeutic targets of Modified Xiaofeng San Decoction in chronic spontaneous urticaria

  2026cites this paper
• The International Guideline for the Definition, Classification, Diagnosis and Management of Urticaria.

  2026cites this paper
• Recurrent Chronic Idiopathic Urticaria Post-hysterectomy and Loss of Xolair Effectiveness: A Case Report

  2025cites this paper
• Зудящий дерматоз: как распознать и облегчить?

  2025cites this paper
• Rapid Clinical Response to Omalizumab Treatment in Pediatric Acute Urticaria Associated with Mycoplasma Infection: A Two-Case Report

  2025cites this paper
• Global, regional, and National burden of urticaria (1990–2021), its potential risk factors, and projections to 2046

  2025cites this paper
• Urticária crônica espontânea: atualização na patogênese e implicações terapêuticas

  2025cites this paper
• Urticaria as a manifestation of Alpha-gal syndrome

  2025cites this paper
• Chronic spontaneous urticaria: update on pathogenesis and therapeutic implications

  2025cites this paper
• Low Total IgE Predicts Non-Response to Omalizumab in Chronic Spontaneous Urticaria: A 10-Year Real-Life Study.

  2025cites this paper
• Exploring the Potential Link: Atherosclerosis and Chronic Spontaneous Urticaria: Analyzing Lipid-Related Atherosclerosis Markers in 203 Patients at a Specialized Urticaria Outpatient Clinic in a Tertiary Center.

  2025cites this paper
• An Atypical Case of Angioedema With Normal C1‐Inhibitor Responding to Both C1‐Inhibitor Concentrate and Omalizumab

  2025cites this paper
• Histopathologic Features in Urticaria and Urticarial Variants: Plasma Cells Should Be Rare

  2025cites this paper
• Global productivity, international collaborations, and research trends in chronic spontaneous urticaria: A bibliometric overview

  2025cites this paper
• Beyond the itch: the complex interplay of immune, neurological, and psychological factors in chronic urticaria

  2025cites this paper
• Endotypes of Chronic Spontaneous Urticaria and Angioedema.

  2025cites this paper
• Efficacy and safety of probiotics as a complementary treatment for urticaria: a systematic review and meta-analysis

  2025cites this paper
• Butyrate Selectively Targets Super‐Enhancers and Transcriptional Networks Associated with Human Mast Cell Function

  2025cites this paper
• Increased prevalence of urticarial diseases and antihistamine/corticosteroid consumption in patients with attention-deficit/hyperactivity disorder

  2025cites this paper
• Decreased 25-hydroxyvitamin D levels in chronic spontaneous urticaria and its relationship with disease activity

  2025cites this paper
• Ubiquitin-specific protease 13 regulates FcεRI-mediated mast cell activation and allergic inflammation via SYK protein modulation.

  2025cites this paper
• Analyze the application and mechanism of Traditional Chinese Medicine in chronic urticaria based on data mining and network pharmacology

  2025cites this paper
• Oxidative Stress and Skin Diseases: The Role of Lipid Peroxidation

  2025cites this paper
• Effect of Dietary Intervention in Paediatric Patients with Chronic Spontaneous Urticaria: Open Labelled Randomised Controlled Trial.

  2025cites this paper
• Chronic inducible urticaria – having more than one is common and clinically relevant

  2025cites this paper
• Update on the Treatment of Chronic Spontaneous Urticaria

  2025cites this paper
• Tezepelumab for the Treatment of Chronic Spontaneous Urticaria: Results of the Phase 2b INCEPTION Study.

  2025cites this paper
• Towards Personalised Therapy in Chronic Spontaneous Urticaria: Advancing From Endotype to Clinical Response

  2025cites this paper
• Anti‐KIT Barzolvolimab for Chronic Spontaneous Urticaria

  2025cites this paper
• IgE in Allergic Diseases

  2025cites this paper
• Diagnostic testing for chronic spontaneous urticaria with or without angioedema: The do's, don't and maybe's

  2025cites this paper
• Utility of the Basophil Reactivity Test in the Clinical Management of People with Severe Uncontrolled Asthma

  2025cites this paper
• Inhibition of pseudo-allergic reactions by vitamin K3 directly targeting GAB1 in mast cells.

  2024cites this paper
• Risk of Anaphylaxis Associated with Cold Urticaria

  2024cites this paper
• Ein Leben ohne Mastzelle?

  2024cites this paper
• Comparative efficacy and safety of the treatment by Omalizumab for chronic idiopathic urticaria in the general population: A systematic review and network meta‐analysis

  2024cites this paper
• Międzynarodowe wytyczne EAACI/GA2LEN/EuroGuiDerm/APAAACI dotyczące definicji, klasyfikacji, diagnostyki i leczenia pokrzywki

  2024cites this paper
• Examining the Interplay of Psychological Factors in Chronic Skin Disease: A Review on Depression, Anxiety, and Stress

  2024cites this paper
• Stressful life events, psychiatric comorbidities and serum neuromediator levels in patients with chronic spontaneous urticaria treated with omalizumab.

  2024influential citation
• Exploring the Impact of IL-33 Gene Polymorphism (rs1929992) on Susceptibility to Chronic Spontaneous Urticaria and Its Association with Serum Interleukin-33 Levels

  2024cites this paper
• The role of the environment in allergic skin disease

  2024cites this paper
• [Acute urticaria].

  2024cites this paper
• Global Burden of Vaccine-Associated Chronic Urticaria, 2010–2023: From the Global Pharmacovigilance Database

  2024cites this paper
• Urticaria aguda

  2024cites this paper
• Research hotspots in urticaria: A bibliometric study of the top 100 most cited articles

  2024cites this paper
• Efficacy evaluation of acupuncture combined with pricking blood therapy in the treatment of chronic spontaneous urticaria: a randomized controlled trial.

  2024cites this paper
• Research Progress on Cholinergic Urticaria

  2024cites this paper
• Alarmins in Chronic Spontaneous Urticaria: Immunological Insights and Therapeutic Perspectives

  2024cites this paper
• Therapies for Chronic Spontaneous Urticaria: Present and Future Developments

  2024cites this paper
• Urticaria: An update on pathophysiology, diagnosis, and management

  2024cites this paper
• Chronic Urticaria in Special Populations: Pediatric, Pregnancy, and the Elderly.

  2024cites this paper
• The decrease in peripheral blood basophils in a mouse model of IgE-induced inflammation involves their migration to lymph nodes.

  2024cites this paper
• Long term safety and efficacy of ligelizumab in the treatment of Japanese patients with chronic spontaneous urticaria.

  2024cites this paper
• Strategien bei chronischer spontaner Urtikaria

  2024cites this paper
• Chronic urticaria associated with Blastocystis hominis infection

  2024cites this paper
• Clinical and Immunological Features of Bronchial Asthma Comorbid Chronic Urticaria: A Retrospective Study

  2024cites this paper
• Increased Neutrophil–Lymphocyte Ratio and Platelet–Lymphocyte Ratio in Chronic and Severe Urticaria

  2024cites this paper
• Efficacy and safety of switching to bilastine, an H1-antihistamine, in patients with refractory chronic spontaneous urticaria (H1-SWITCH): a multicenter, open-label, randomized, parallel-group comparative study

  2024cites this paper
• The relationship between serum transglutaminase-2 levels and the severity of chronic spontaneous urticaria

  2024cites this paper
• PTGS2: A potential immune regulator and therapeutic target for chronic spontaneous urticaria.

  2024cites this paper
• Disease modification in chronic spontaneous urticaria

  2024cites this paper
• Beyond the classic players: Mas‐related G protein‐coupled receptor member X2 role in pruritus and skin diseases

  2024cites this paper
• Five-Membered Nitrogen Heterocycles Angiotensin-Converting Enzyme (ACE) Inhibitors Induced Angioedema: An Underdiagnosed Condition

  2024cites this paper
• TGF-β, IL-1β, IL-6 levels and TGF-β/Smad pathway reactivity regulate the link between allergic diseases, cancer risk, and metabolic dysregulations

  2024cites this paper
• Real-World Clinical Experience with Oral Cyclosporine in Antihistamine Refractory Cases of Chronic Spontaneous Urticaria

  2024cites this paper
• Key differences between chronic inducible and spontaneous urticaria

  2024cites this paper
• Risk calculator of the clinical response to antihistamines in chronic urticaria: Development and internal validation

  2024cites this paper
• Chronic Urticaria in Pregnancy: Physiologic and Hormonal Background for an Immune Skin Disease

  2024cites this paper
• Dupilumab in patients with chronic spontaneous urticaria (LIBERTY-CSU CUPID): two randomized, double-blind, placebo-controlled, phase 3 trials.

  2024cites this paper
• Correlation between double‐stranded DNA and acute urticaria

  2024cites this paper
• Targeting Histamine Receptor 4 in Cholinergic Urticaria with Izuforant (LEO 152020): Results from a Phase 2a, Randomised, Double-Blind, Placebo-Controlled, Multicentre, Crossover trial.

  2024cites this paper
• Atopy in chronic urticaria: an important yet overlooked issue

  2024cites this paper
• Detecting Changes in Mast Cell Numbers vs. Activation in Human Disease: A Roadblock for Current Biomarkers?

  2024cites this paper
• Serum Concentration of IL-5 Receptor (IL-5R) and Associations with Disease Severity in Patients with Chronic Spontaneous Urticaria (CSU) and Atopic Dermatitis (AD)

  2024cites this paper
• Identification of pyruvic and maleic acid as potential markers for disease activity and prognosis in chronic urticaria.

  2024cites this paper
• Omalizumab for the Treatment of Refractory Acute Urticaria.

  2024cites this paper
• Immunopathogenesis of urticaria: a clinical perspective on histamine and cytokine involvement

  2024influential citation
• The Alarmin Triad—IL-25, IL-33, and TSLP—Serum Levels and Their Clinical Implications in Chronic Spontaneous Urticaria

  2024cites this paper
• Chronic spontaneous urticaria: diagnosis, treatment, and management

  2024cites this paper
• What can be learned from real-world data about chronic spontaneous urticaria?

  2024cites this paper
• Krankheitsaktivität und Therapie regelmäßig reevaluieren

  2024cites this paper
• Dupilumab Reduces Urticaria Activity, Itch, and Hives in Patients with Chronic Spontaneous Urticaria Regardless of Baseline Serum Immunoglobulin E Levels

  2024cites this paper
• Autoimmune Mast Cell Activation Test as a Diagnostic Tool in Chronic Spontaneous Urticaria

  2024cites this paper
• Solar urticaria involves rapid mast cell STAT3 activation and neutrophil recruitment, with FcεR1 as an upstream regulator.

  2024cites this paper
• Efficacy and safety of combinations of H1 antihistamines in the treatment of urticaria: A scoping review.

  2024cites this paper
• Beyond Allergies—Updates on The Role of Mas-Related G-Protein-Coupled Receptor X2 in Chronic Urticaria and Atopic Dermatitis

  2024cites this paper
• Effects of acupuncture on serotonin, histamine, substance P, and tryptase levels at sensitized points in model rats with knee osteoarthritis

  2024cites this paper
• Eosinophilic cationic protein and D-Dimer are potential biomarkers to predict response to antihistamines but not to omalizumab in chronic spontaneous urticaria

  2024cites this paper
• Chronic spontaneous urticaria: Evidence of systemic microcirculatory changes

  2024cites this paper
• Elevated cutaneous expression of stem cell factor in chronic spontaneous urticaria: a prospective cohort study.

  2024cites this paper
• Knockdown of miR-155 alleviates skin damage in rats with chronic spontaneous urticaria by modulating the JAK/STAT signaling pathway

  2024cites this paper
• Changes in Serum IL-12 Levels following the Administration of H1-Antihistamines in Patients with Chronic Spontaneous Urticaria

  2024cites this paper
• Impact of Gut Microbiome Dynamics on Epidermal Health

  2024cites this paper